Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b randomized double-blind placebo-controlled trial of KPCXM18 Injection in acute ischemic stroke
CTR20254329Phase 2Active
- Sponsor
- Kunyao Group
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ginsenotriol disuccinate sodium in ischemic stroke, sponsored by Kunyao Group. Started Nov 2025; status: active.
02
Drugs
ginsenotriol disuccinate sodium
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20254329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254329.